In 2010, the FDA has announced that the Zerona® Laser (aka Erchonia ML Scanner) has demonstrated safety and efficacy as a non-invasive body-contouring, fat-loss and inch-loss treatment and has awarded the Zerona® (Erchonia, TX) with its 510(K) Class II device approval: K082609. Erchonia is the company that manufactures the Zerona® Laser.

The FDA described the non-invasive Zerona® ‘s mechanism of action… “disruption of the adipocyte cells within the fat layer for the release of fat and lipids from these cells for non-invasive aesthetic use” and as a Class II device: “Low Level Laser System for Aesthetic Use.”

Through a double blind, randomized, multi-site and placebo-controlled study, the Zerona® procedure is proven to be an effective non-invasive body contouring procedure. On average, patients lost on average 3.64 inches from the circumference of their waist, hip and thighs, whereas the placebo group only lost an average of a half of an inch.

The Zerona® cold lasers provide patients with a safer alternative to surgical procedures, which can result in bruising, swelling, and damage to other tissues. There is no need to wear compression garments or bandages with Zerona® and since there is no pain, there is no need for anesthesia. Unlike other non-invasive approaches, Zerona® low-level lasers do not rely on heating tissue, which can cause discomfort. There is no downtime, so patients can resume their normal activities immediately after receiving treatment.

REFERENCE RESOURCES:

Zerona : : Listed on CorporateB2Bprofiles.com

Zerona : : Profile on CorporateDataNews.com

Zerona : : Article at CorporateReferences.com

Zerona : : Registered with CorporateHandshake.com

Zerona : : Profile at CorporateDataMining.com